Now showing items 31-40 of 609
Infarct Size as Predictor of Systolic Functional Recovery after Myocardial Infarction
(Arquivos Brasileiros Cardiologia, 2014-06-01)
Background: The effects of modern therapy on functional recovery after acute myocardial infarction (AMI) are unknown.Objectives: To evaluate the predictors of systolic functional recovery after anterior AMI in patients ...
Cell therapy prevents structural, functional and molecular remodeling of remote non-infarcted myocardium
(Elsevier Ireland LtdClareIrlanda, 2013)
The Antiapoptotic Effect of Granulocyte Colony-stimulating Factor Reduces Infarct Size and Prevents Heart Failure Development in Rats
Background/Aim. Granulocyte colony-stimulating factor (G-CSF) reduces myocardial injury and improves cardiac function after myocardial infarction (MI). We investigated the early alterations provided by G-CSF and the chronic ...
Right atrial lipoma resection and partial reconstruction using bovine pericardium
(Soc Brasil Cirurgia CardiovascSao Paulo SpBrasil, 2009)
Combined effects of age and diet-induced obesity on biochemical parameters and cardiac energy metabolism in rats
Obesity is often associated with decreased fat oxidation and aging is a well-recognized risk factor for cardiovascular disease. This study investigated calorimetric and morphometric parameters, as well as the glucose levels, ...
Effect of an Ilex paraguariensis (yerba mate) extract on infarct size in isolated rat hearts: The mechanisms involved
(Royal Society of Chemistry, 2016-02)
Tea made from Ilex paraguariensis (IP) dried and minced leaves is a beverage widely consumed by large populations in South America as a source of caffeine (stimulant action) and for its medicinal properties. However, there ...
Memantine prevents cardiomyocytes nuclear size reduction in the left ventricle of rats exposed to cold stress
(Faculdade de Medicina / USP, 2009-01-01)
OBJECTIVES: Memantine is an N-methyl-d-aspartate (NMDA) glutamate receptor antagonist used to treat Alzheimer's disease. Previous studies have suggested that receptor blockers act as neuroprotective agents; however, no ...